Data / Drug companies / Kobayashi Healthcare International, Inc.
Kobayashi Healthcare International, Inc.: 19 products in the FDA NDC directory, labeler code 52389
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Kobayashi Healthcare International, Inc. (labeler code 52389) lists 19 products in the FDA National Drug Code Directory, covering 13 finished drugs by generic name. By type: 19 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on December 19, 2025.
The request: Watch Kobayashi Healthcare International, Inc. (FDA labeler code 52389): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 52389
- Products in commercial distribution
- 19
- Packages
- 40
- Finished drugs by generic name
- 13
- Prescription products
- 0
- Over the counter products
- 19
- Flagged as original packager
- 19 of 19 products that carry the flag
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- February 1, 1992
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 15 | 78.9% |
| Unapproved homeopathic products | 3 | 15.8% |
| Other unapproved drugs | 1 | 5.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 19 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Clotrimazole | 3 | 98 |
| Sepia | 2 | 8 |
| Sodium citrate | 2 | 1 |
| Coal tar | 2 | 22 |
| Caffeine | 2 | 38 |
| Acetaminophen, pamabrom | 1 | 2 |
| Sulphur | 1 | 10 |
| Phenazopyridine hydochloride | 1 | 1 |
| Acetaminophen, aspirin, caffeine | 1 | 48 |
| Caffeine, magnesium salicylate | 1 | 1 |
| Acetaminophen, caffeine | 1 | 14 |
| Tolnaftate | 1 | 99 |
| Pamabrom | 1 | 7 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 7 | 36.8% |
| Soap | 2 | 10.5% |
| Tablet, chewable | 2 | 10.5% |
| Gel | 2 | 10.5% |
| Liquid | 2 | 10.5% |
| Ointment | 1 | 5.3% |
| Lotion/shampoo | 1 | 5.3% |
| Tablet, coated | 1 | 5.3% |
| Cream | 1 | 5.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Central Nervous System Stimulant | 5 |
| Methylxanthine | 5 |
| Azole Antifungal | 3 |
| Anti-coagulant | 2 |
| Calculi Dissolution Agent | 2 |
| Nonsteroidal Anti-inflammatory Drug | 1 |
| Platelet Aggregation Inhibitor | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Fungicure Night Cream | 52389-681 | Cream | Over the counter monograph drugs | December 19, 2025 |
| Nauzene Chewables Ginger Honey | 52389-677 | Tablet, chewable | Over the counter monograph drugs | February 17, 2025 |
| BackAid | 52389-253 | Tablet, film coated | Over the counter monograph drugs | October 31, 2024 |
| Psoriasin In-Shower Treatment | 52389-670 | Lotion/shampoo | Over the counter monograph drugs | March 3, 2021 |
| Fungicure Anti-Fungal Liquid | 52389-298 | Liquid | Over the counter monograph drugs | October 13, 2020 |
| Psoriasin Deep Moisturizing | 52389-752 | Ointment | Over the counter monograph drugs | June 21, 2019 |
| Fungicure AF Wash | 52389-666 | Soap | Unapproved homeopathic products | March 1, 2018 |
| Fungicure Anti-Fungal Wash | 52389-226 | Soap | Unapproved homeopathic products | March 7, 2016 |
| Fungicure Liquid Gel | 52389-733 | Gel | Over the counter monograph drugs | December 31, 2015 |
| Diurex Ultimate | 52389-656 | Tablet, film coated | Over the counter monograph drugs | October 31, 2015 |
| Arthriten Inflammatory Pain Formula | 52389-237 | Tablet, film coated | Over the counter monograph drugs | July 23, 2012 |
| Fungicure Intensive | 52389-600 | Liquid | Over the counter monograph drugs | June 5, 2008 |
| Uricalm Maximum Strength | 52389-241 | Tablet, film coated | Other unapproved drugs | April 29, 2008 |
| Prosacea | 52389-173 | Gel | Unapproved homeopathic products | February 6, 2006 |
| Diurex Ultra | 52389-155 | Tablet, film coated | Over the counter monograph drugs | September 1, 2005 |
| Diurex Water Pills | 52389-306 | Tablet, coated | Over the counter monograph drugs | May 15, 2005 |
| Nauzene | 52389-242 | Tablet, chewable | Over the counter monograph drugs | July 8, 2000 |
| Diurex Max | 52389-249 | Tablet, film coated | Over the counter monograph drugs | December 20, 1995 |
| BackAid Max | 52389-153 | Tablet, film coated | Over the counter monograph drugs | February 1, 1992 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.